Jan 9 (Reuters) - Moderna Inc said on Monday it
generated about $18.4 billion in COVID-19 vaccine sales in 2022,
meeting its forecast of $18 billion-$19 billion for the year.The company also forecast minimum COVID-19 vaccine sales of
about $5 billion in 2023, compared with its previous forecast of
$4.5 billion to $5.5 billion in November.The COVID vaccine maker continues to expect additional
contracts for 2023, it said.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini
Ganguli)